Literature DB >> 6162992

Induction of intestinal tumors in rats by dextran sulfate sodium.

I Hirono, K Kuhara, S Hosaka, S Tomizawa, L Golberg.   

Abstract

The carcinogenicity of dextran sulfate sodium was studied in inbred ACI rats. In group 1, 10 male rats were fed a 10% dextran sulfate sodium diet; in group 2, 14 male and 12 female rats were fed a 5% dextran sulfate sodium diet; and in the control group, 9 male and 9 female rats were given the basal diet without dextran sulfate sodium. After the start of the feeding regimen, all rats given the 10% dextran sulfate sodium diet died of severe diarrhea and anemia within 14 days and 15 of 23 surviving rats fed a 5% dextran sulfate sodium diet developed intestinal tumors between 134 and 215 days. These tumors were induced in the colon and cecum and consisted of adenomas, adenocarcinomas, and papillomas.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6162992

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  15 in total

1.  Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis.

Authors:  Darren N Seril; Jie Liao; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2007-05       Impact factor: 4.784

2.  Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice.

Authors:  L G Axelsson; E Landström; T J Goldschmidt; A Grönberg; A C Bylund-Fellenius
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

3.  A simple, quantitative method using alginate gel to determine rat colonic tumor volume in vivo.

Authors:  Amy A Irving; Lindsay B Young; Jennifer K Pleiman; Michael J Konrath; Blake Marzella; Michael Nonte; Justin Cacciatore; Madeline R Ford; Linda Clipson; James M Amos-Landgraf; William F Dove
Journal:  Comp Med       Date:  2014-04       Impact factor: 0.982

4.  Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity.

Authors:  N Diaz-Granados; K Howe; J Lu; D M McKay
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

5.  Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats.

Authors:  S Kishimoto; K Haruma; A Tari; K Sakurai; M Nakano; Y Nakagawa
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

6.  Histochemical study of colonic cancer in experimental colitis of rats.

Authors:  T Tamaru; H Kobayashi; S Kishimoto; G Kajiyama; F Shimamoto; W R Brown
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

7.  Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium.

Authors:  M Yamada; T Ohkusa; I Okayasu
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

8.  Intracellular Campylobacter-like organism from ferrets and hamsters with proliferative bowel disease is a Desulfovibrio sp.

Authors:  J G Fox; F E Dewhirst; G J Fraser; B J Paster; B Shames; J C Murphy
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

9.  Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis.

Authors:  S Kishimoto; H Kobayashi; S Shimizu; K Haruma; T Tamaru; G Kajiyama; A Miyoshi
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

10.  Increased susceptibility of chronic ulcerative colitis-induced carcinoma development in DNA repair enzyme Ogg1 deficient mice.

Authors:  Jie Liao; Darren N Seril; Gary G Lu; Meng Zhang; Shinya Toyokuni; Allison L Yang; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2008-08       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.